Flagship Ventures Fund 2004 L P's Net Worth
$20.9 Million
Who is Flagship Ventures Fund 2004 L P?
Flagship Ventures Fund 2004 L P has an estimated net worth of $20.9 Million. This is based on reported shares across multiple companies, which include TETRAPHASE PHARMACEUTICALS INC, BIND Therapeutics, Inc, Quanterix Corp, CONCERT PHARMACEUTICALS, INC., T2 Biosystems, Inc., and HELICOS BIOSCIENCES CORP.
SEC CIK
Flagship Ventures Fund 2004 L P's CIK is 0001299790
Past Insider Trading and Trends
2013 was Flagship Ventures Fund 2004 L P's most active year for acquiring shares with 6 total transactions. Flagship Ventures Fund 2004 L P's most active month to acquire stocks was the month of February. 2013 was Flagship Ventures Fund 2004 L P's most active year for disposing of shares, totalling 5 transactions. Flagship Ventures Fund 2004 L P's most active month to dispose stocks was the month of February. 2013 saw Flagship Ventures Fund 2004 L P paying a total of $3,442,768.00 for 2,057,673 shares, this is the most they've acquired in one year. In 2013 Flagship Ventures Fund 2004 L P cashed out on 45,409,661 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TETRAPHASE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.06M |
$7.00 |
—
| 2.06M |
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Quanterix Corp (QTRX) Snapshot price: $11.99
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.03M |
—
|
—
| 2.03M |
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CONCERT PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,919.47% | 623.98K |
—
|
—
| 656.49K |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
T2 Biosystems, Inc. (TTOO) Snapshot price: $2.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.37M |
—
|
—
| 2.37M |
Aug 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIND Therapeutics, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.56M |
$15.00 |
—
| 1.56M |
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |